Affiliation:
1. Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA
2. Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA
Abstract
Lysophosphatidic acid (LPA) is a lipid mediator that binds to G-protein-coupled receptors, eliciting a wide variety of responses in mammalian cells. Lyso-phospholipids generated via phospholipase A2 (PLA2) can be converted to LPA by a lysophospholipase D (lyso-PLD). Secreted lyso-PLDs have been studied in more detail than membrane-localized lyso-PLDs. This study utilized in vitro enzyme assays with fluorescent substrates to examine LPA generation in membranes from multiple mammalian cell lines (PC12, rat pheochromocytoma; A7r5, rat vascular smooth muscle; Rat-1, rat fibroblast; PC-3, human prostate carcinoma; and SKOV-3 and OVCAR-3, human ovarian carcinoma). The results show that membranes contain a lyso-PLD activity that generates LPA from a fluorescent alkyl-lyso-phosphatidylcholine, as well as from naturally occurring acyl-linked lysophospholipids. Membrane lyso-PLD and PLD activities were distinguished by multiple criteria, including lack of effect of PLD2 over-expression on lyso-PLD activity and differential sensitivities to vanadate (PLD inhibitor) and iodate (lyso-PLD inhibitor). Based on several lines of evidence, including siRNA knockdown, membrane lyso-PLD is distinct from autotaxin, a secreted lyso-PLD. PC-3 cells express GDE4 and GDE7, recently described lyso-PLDs that localize to membranes. These findings demonstrate that membrane-associated lyso-D activity, expressed by multiple mammalian cell lines, can contribute to LPA production.
Funder
National Institutes of Health
U.S. Department of Defense
UNCF/Merck Science Research Dissertation Fellowship
the University Research Committee of the Medical University of South Carolina
the College of Pharmacy and Pharmaceutical Sciences at Washington State University
Reference84 articles.
1. Lysophospholipid receptors;Fukushima;Ann. Rev. Pharm. Toxicol.,2001
2. Role of lysophophatidic acid and its receptors in health and disease; novel therapeutic strategies;Geraldo;Signal Transduct. Target. Ther.,2021
3. Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids;Goetzl;Prost. Lipid Med.,2001
4. Balijepalli, P., Sitton, C.C., and Meier, K.E. (2021). Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?. Cells, 10.
5. The bioactive phospholipid lysophophatidic acid is released from activated platelets;Eichholtz;Biochem. J.,1993